Icon

ISTODAX (nda022393)- (10MG/VIAL)

ROMIDEPSIN BRISTOL-MYERS
10MG/VIAL
Yes No
2021-Aug-22 2014-Nov-05
2018-Jun-16 None
None No
ISTODAX is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy.
1 0 1
Total Other Developers 4
Drugs with Suitability No
10MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* **** *** ********* **** ***, *** *********** **** ****** ****, ***** ******, *** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.